Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rigel Suzuki

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Frontiers in Cellular and Infection Microbiology|June 1, 2023
A third dose of the BNT162b2 mRNA vaccine sufficiently improves the neutralizing activity against SARS-CoV-2 variants in liver transplant recipientsTakahiro Tomiyama, Rigel Suzuki, Noboru Harada, et al.
Iscience|April 19, 2024
Akaluc bioluminescence offers superior sensitivity to track <i>in vivo</i> dynamics of SARS-CoV-2 infectionTomokazu Tamura, Hayato Ito, Shiho Torii, et al.
Plos Pathogens|March 27, 2023
Increased flexibility of the SARS-CoV-2 RNA-binding site causes resistance to remdesivirShiho Torii, Kwang Su Kim, Jun Koseki, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
A non-spike nucleocapsid R204P mutation in SARS-CoV-2 Omicron XEC enhances inflammation and pathogenicityShuhei Tsujino, Masumi Tsuda, Jumpei Ito, et al.
Nature Communications|December 14, 2025
A non-spike nucleocapsid R204P mutation in SARS-CoV-2 Omicron XEC enhances inflammation and pathogenicityShuhei Tsujino, Masumi Tsuda, Sayaka Deguchi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 24, 2026
Analysis of HBV Genome Integration in Patients With HBV-Previously Infected NBNC-HCCTomoya Saito, Rigel Suzuki, Akhinur Rahman, et al.
Nature Communications|May 19, 2023
saRNA vaccine expressing membrane-anchored RBD elicits broad and durable immunity against SARS-CoV-2 variants of concernMai Komori, Takuto Nogimori, Amber L Morey, et al.
Antiviral Research|August 30, 2025
Characterization of remdesivir resistance mutations in COVID-19 patients with various immunosuppressive diseasesTakaya Ichikawa, Tomokazu Tamura, Naganori Nao, et al.
Journal of Virology|September 23, 2025
Evolution of BA.2.86 to JN.1 reveals that functional changes in non-structural viral proteins are required for fitness of SARS-CoV-2Shuhei Tsujino, Masumi Tsuda, Naganori Nao, et al.
Structure (London, England : 1993)|January 16, 2024
Rational in silico design identifies two mutations that restore UT28K SARS-CoV-2 monoclonal antibody activity against Omicron BA.1Tatsuhiko Ozawa, Yoshiki Ikeda, Liuan Chen, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Frontiers in Cellular and Infection Microbiology|June 1, 2023
A third dose of the BNT162b2 mRNA vaccine sufficiently improves the neutralizing activity against SARS-CoV-2 variants in liver transplant recipientsTakahiro Tomiyama, Rigel Suzuki, Noboru Harada, et al.
Iscience|April 19, 2024
Akaluc bioluminescence offers superior sensitivity to track <i>in vivo</i> dynamics of SARS-CoV-2 infectionTomokazu Tamura, Hayato Ito, Shiho Torii, et al.
Plos Pathogens|March 27, 2023
Increased flexibility of the SARS-CoV-2 RNA-binding site causes resistance to remdesivirShiho Torii, Kwang Su Kim, Jun Koseki, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
A non-spike nucleocapsid R204P mutation in SARS-CoV-2 Omicron XEC enhances inflammation and pathogenicityShuhei Tsujino, Masumi Tsuda, Jumpei Ito, et al.
Nature Communications|December 14, 2025
A non-spike nucleocapsid R204P mutation in SARS-CoV-2 Omicron XEC enhances inflammation and pathogenicityShuhei Tsujino, Masumi Tsuda, Sayaka Deguchi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 24, 2026
Analysis of HBV Genome Integration in Patients With HBV-Previously Infected NBNC-HCCTomoya Saito, Rigel Suzuki, Akhinur Rahman, et al.
Nature Communications|May 19, 2023
saRNA vaccine expressing membrane-anchored RBD elicits broad and durable immunity against SARS-CoV-2 variants of concernMai Komori, Takuto Nogimori, Amber L Morey, et al.
Antiviral Research|August 30, 2025
Characterization of remdesivir resistance mutations in COVID-19 patients with various immunosuppressive diseasesTakaya Ichikawa, Tomokazu Tamura, Naganori Nao, et al.
Journal of Virology|September 23, 2025
Evolution of BA.2.86 to JN.1 reveals that functional changes in non-structural viral proteins are required for fitness of SARS-CoV-2Shuhei Tsujino, Masumi Tsuda, Naganori Nao, et al.
Structure (London, England : 1993)|January 16, 2024
Rational in silico design identifies two mutations that restore UT28K SARS-CoV-2 monoclonal antibody activity against Omicron BA.1Tatsuhiko Ozawa, Yoshiki Ikeda, Liuan Chen, et al.
Pageof 5